Cargando…
Risk Factors and Prognosis of Early Recurrence in Stage I–II Endometrial Cancer: A Large-Scale, Multi-Center, and Retrospective Study
OBJECTIVE: The aim of the present study was to determine overall survival (OS) and risk factors associated with early recurrence in patients with FIGO I–II stage endometrial carcinoma (EC). METHODS: Clinical features were retrospectively extracted from the database of China Endometrial Cancer Consor...
Autores principales: | Dou, Yingyu, Song, Kun, Fu, Yu, Shen, Yuanming, Zhang, Chuyao, Yao, Shuzhong, Xu, Congjian, Xia, Min, Lou, Ge, Liu, Jihong, Lin, Bei, Wang, Jianliu, Zhao, Weidong, Zhang, Jieqing, Cheng, Wenjun, Guo, Hongyan, Guo, Ruixia, Xue, Fengxia, Wang, Xipeng, Han, Lili, Zhao, Xia, Li, Xiaomao, Zhang, Ping, Zhao, Jianguo, Ma, Jiezhi, Li, Wenting, Yang, Xiaohang, Wang, Zizhuo, Liu, Jingbo, Fang, Yong, Li, Kezhen, Chen, Gang, Sun, Chaoyang, Cheng, Xiaodong, Jiang, Jie, Wang, Beibei, Luo, Danfeng, Kong, Beihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046937/ https://www.ncbi.nlm.nih.gov/pubmed/35492356 http://dx.doi.org/10.3389/fmed.2022.808037 |
Ejemplares similares
-
Implications of Isolated Para-Aortic Lymph Node Metastasis in Endometrial Cancer: A Large-Scale, Multicenter, and Retrospective Study
por: Li, Wenting, et al.
Publicado: (2021) -
Prognostic-Related Metabolic Score for Survival Prediction in Early-Stage Endometrioid Endometrial Cancer: A Multi-Center and Retrospective Study
por: Wang, Zizhuo, et al.
Publicado: (2022) -
It is not the time to abandon intraoperative frozen section in endometrioid adenocarcinoma: A large‐scale, multi‐center, and retrospective study
por: Yang, Xiaohang, et al.
Publicado: (2023) -
Preoperative and intraoperative assessment of myometrial invasion in patients with FIGO stage I non-endometrioid endometrial carcinoma—a large-scale, multi-center, and retrospective study
por: Yang, Xiaohang, et al.
Publicado: (2023) -
Inhibiting the IRE1α Axis of the Unfolded Protein Response Enhances the Antitumor Effect of AZD1775 in TP53 Mutant Ovarian Cancer
por: Xiao, Rourou, et al.
Publicado: (2022)